PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

MIT: Removable 'cloak' for nanoparticles helps them target tumors

New MIT particles could be used to deliver cancer drugs to nearly any type of tumor

2011-05-04
(Press-News.org) CAMBRIDGE, Mass. -- MIT chemical engineers have designed a new type of drug-delivery nanoparticle that exploits a trait shared by almost all tumors: They are more acidic than healthy tissues.

Such particles could target nearly any type of tumor, and can be designed to carry virtually any type of drug, says Paula Hammond, a member of the David H. Koch Institute for Integrative Cancer Research at MIT and senior author of a paper describing the particles in the journal ACS Nano.

Like most other drug-delivering nanoparticles, the new MIT particles are cloaked in a polymer layer that protects them from being degraded by the bloodstream. However, the MIT team, including lead author and postdoctoral associate Zhiyong Poon, designed this outer layer to fall off after entering the slightly more acidic environment near a tumor. That reveals another layer that is able to penetrate individual tumor cells.

In the ACS Nano paper, which went online April 23, the researchers reported that, in mice, their particles can survive in the bloodstream for up to 24 hours, accumulate at tumor sites and enter tumor cells.

The new MIT approach differs from that taken by most nanoparticle designers. Typically, researchers try to target their particles to a tumor by decorating them with molecules that bind specifically to proteins found on the surface of cancer cells. The problem with that strategy is that it's difficult to find the right target — a molecule found on all of the cancer cells in a particular tumor, but not on healthy cells. Also, a target that works for one type of cancer might not work for another.

Hammond and her colleagues decided to take advantage of tumor acidity, which is a byproduct of its revved-up metabolism. Tumor cells grow and divide much more rapidly than normal cells, and that metabolic activity uses up a lot of oxygen, which increases acidity. As the tumor grows, the tissue becomes more and more acidic.

To build their targeted particles, the researchers used a technique called "layer-by-layer assembly." This means each layer can be tailored to perform a specific function.

When the outer layer (made of polyethylene glycol, or PEG) breaks down in the tumor's acidic environment, a positively charged middle layer is revealed. That positive charge helps to overcome another obstacle to nanoparticle drug delivery: Once the particles reach a tumor, it's difficult to get them to enter the cells. Particles with a positive charge can penetrate the negatively charged cell membrane, but such particles can't be injected into the body without a "cloak" of some kind because they would also destroy healthy tissues.

The nanoparticles' innermost layer can be a polymer that carries a cancer drug, or a quantum dot that could be used for imaging, or virtually anything else that the designer might want to deliver, says Hammond, who is the Bayer Professor of Chemical Engineering at MIT.

Other researchers have tried to design nanoparticles that take advantage of tumors' acidity, but Hammond's particles are the first that have been successfully tested in living animals.

The researchers are planning to further develop these particles and test their ability to deliver drugs in animals. Hammond says she expects it could take five to 10 years of development before human clinical trials could begin.

Hammond's team is also working on nanoparticles that can carry multiple payloads. For example, the outer PEG layer might carry a drug or a gene that would "prime" the tumor cells to be susceptible to another drug carried in the particle's core.

INFORMATION:

END



ELSE PRESS RELEASES FROM THIS DATE:

Ecstasy associated with chronic change in brain function

Ecstasy associated with chronic change in brain function
2011-05-04
Ecstasy – the illegal "rave" drug that produces feelings of euphoria and emotional warmth – has been in the news recently as a potential therapeutic. Clinical trials are testing Ecstasy in the treatment of post-traumatic stress disorder. But headlines like one in Time magazine's health section in February – "Ecstasy as therapy: have some of its negative effects been overblown?" – concern Ronald Cowan, M.D., Ph.D., associate professor of Psychiatry. His team reports in the May issue of Neuropsychopharmacology that recreational Ecstasy use is associated with a chronic ...

Webcam technology used to measure medications' effects on the heart

2011-05-04
Boston, MA – A common component in webcams may help drug makers and prescribers address a common side-effect of drugs called cardiotoxicity, an unhealthy change in the way the heart beats. Researchers at Brigham and Women's Hospital (BWH) have used the basic webcam technology to create a tool to look at the effects of medications in real time on heart cells, called cardiomyocytes. These findings were published in the journal, Lab on a Chip on April 11, 2011. Researchers developed a cost-effective, portable cell-based biosensor for real time cardiotoxicity detection using ...

'Nutcracker Man' had fundamentally different diet

Nutcracker Man had fundamentally different diet
2011-05-04
An ancient, bipedal hominid needs a new nickname. Paranthropus boisei, a 2.3 million to 1.2 million-year-old primate, whom researchers say is an early human cousin, probably didn't crack nuts at all as his common handle suggests. "Nutcracker Man" most likely ate grass and possibly sedges, said geochemist Thure Cerling, lead author of a study published in the May 2 online edition of the journal Proceedings of the National Academy of Sciences. Cerling and colleagues determined P. boisei's diet by analyzing carbon isotope ratios in the tooth enamel of 24 teeth from 22 ...

Formidable fungal force counters biofuel plant pathogens

2011-05-04
WALNUT CREEK, Calif.—Fungi play significant ecological and economic roles. They can break down organic matter, cause devastating agricultural blights, enter into symbiotic relationships to protect and nourish plants, or offer a tasty repast. For industrial applications, fungi provide a source of enzymes to catalyze such processes as generating biofuels from plant biomass. One large fungal group with such enzymes are the rust plant pathogens which cannot survive on their own so they use crops as hosts, leading to reduced yields and potentially hindering efforts to grow biomass ...

Marine snails get a metabolism boost

2011-05-04
Durham, NC – Most of us wouldn't consider slow-moving snails to be high-metabolism creatures. But at one point in the distant past, snail metabolism sped up, says a new study of marine snails in the journal Paleobiology. "Many of the marine snails we recognize today — such as abalone, conchs, periwinkles and whelks — require more than twice as much energy to survive as their ancestors did," said co-author Seth Finnegan of the California Institute of Technology. The findings come from a new analysis of snail fossils formed one to two hundred million years ago, during ...

Pistachios pummel pretzels as a weight-wise snack

Pistachios pummel pretzels as a weight-wise snack
2011-05-04
LOS ANGELES, May 3, 2011 – When it comes to healthy snacking and weight management, a new study bolsters the long-held view that not all calories are created equal. According to nutrition researchers at UCLA, choosing to snack on pistachios rather than pretzels as part of a healthy diet not only supports your body mass index (BMI) goals, but can support heart health too. The study, recently published in the Journal of the American College of Nutrition is especially significant in today's diet as snack foods account for more than a quarter of the total caloric intake ...

Rutgers offers hope in new treatment for spinal cord injuries

2011-05-04
Rutgers researchers have developed an innovative new treatment that could help minimize nerve damage in spinal cord injuries, promote tissue healing and minimize pain. After a spinal cord injury there is an increased production of a protein (RhoA) that blocks regeneration of nerve cells that carry signals along the spinal cord and prevents the injured tissue from healing. Scientists at the W.M. Keck Center for Collaborative Neuroscience and Quark Pharmaceuticals Inc. have developed a chemically synthesized siRNA molecule that decreases the production of the RhoA protein ...

GEN reports on novel noninvasive tests for early cancer detection

GEN reports on novel noninvasive tests for early cancer detection
2011-05-04
New Rochelle, NY, May 3, 2011—Researchers at last month's AACR conference in Orlando demonstrated that they are intensifying their efforts to identify and validate various types of biomarkers that are detectable in readily accessible bodily fluids such as blood and urine, reports Genetic Engineering & Biotechnology News (GEN). The goal is to detect biosignatures that are more specific and sensitive than existing diagnostic modalities, according to the May 1 issue of GEN (http://www.genengnews.com/gen-articles/cancer-detection-improved-with-noninvasive-testing/3639/). "The ...

Texas Bill Would Raise Speed Limit on Some Texas Highways to 85 MPH

2011-05-04
Texas Bill Would Raise Speed Limit on Some Texas Highways to 85 MPH A bill recently passed in the Texas House of Representatives would raise the speed limit on some Texas highways from 80 to 85 mph -- a move that highway safety advocates are already cautioning against. The Texas Senate is currently considering a similar measure. The Lone Star State already has over 500 miles of highways with speed limits set at 80 mph -- the highest in the nation, along with certain Utah highways. Critics say that the move would be tantamount to a license for motorists and truckers ...

Genome duplication encourages rapid adaptation of plants

2011-05-04
Plants adapt to the local weather and soil conditions in which they grow, and these environmental adaptations are known to evolve over thousands of years as mutations slowly accumulate in plants' genetic code. But a University of Rochester biologist has found that at least some plant adaptations can occur almost instantaneously, not by a change in DNA sequence, but simply by duplication of existing genetic material. Justin Ramsey's findings are published in the current Proceedings of the National Academy of Sciences. While nearly all animals have two sets of chromosomes—one ...

LAST 30 PRESS RELEASES:

Ancient groundwater records reveal regional vulnerabilities to climate change

New monstersaur species a ‘goblin prince’ among dinosaurs

Father-daughter bonding helps female baboons live longer

New species of armored, monstersaur lizard that lived alongside dinosaurs identified by NHM paleontologists

Puberty blockers do not cause problems with sexual functioning in transgender adults

High levels of antihistamine drugs can reduce fitness gains

‘Virtual ward’ bed uses 4 times less carbon than traditional inpatient bed

Cannabis use linked to doubling in risk of cardiovascular disease death

Weight loss behaviors missing in tools to diagnose eating disorders

Imaging-based STAMP technique democratizes single-cell RNA research

Hyperspectral sensor pushes weed science a wave further

War, trade and agriculture spread rice disease across Africa

Study identifies a potential treatment for obesity-linked breathing disorder

From single cells to complex creatures: New study points to origins of animal multicellularity

Language disparities in continuous glucose monitoring for type 2 diabetes

New hormonal pathway links oxytocin to insulin secretion in the pancreas

Optimal management of erosive esophagitis: An evidence-based and pragmatic approach

For patients with multiple cancers, a colorectal cancer diagnosis could be lifesaving — or life-threatening

Digital inhalers may detect early warning signs of COPD flare-ups

Living near harmful algal blooms reduces life expectancy with ALS

Chemical analysis of polyphenolic content and antioxidant screening of 17 African propolis samples using RP-HPLC and spectroscopy

Mount Sinai and Cancer Research Institute team up to improve patient outcomes in immunotherapy

Suicide risk elevated among young adults with disabilities

Safeguarding Mendelian randomization: editorial urges rethink in methodological rigor

Using AI to find persuasive public health messages and automate real-time campaigns

Gene therapy for glaucoma

Teaching robots to build without blueprints

Negative perception of scientists working on AI

How disrupted daily rhythms can affect adolescent brain development

New use for old drug: study finds potential of heart drug for treating growth disorders

[Press-News.org] MIT: Removable 'cloak' for nanoparticles helps them target tumors
New MIT particles could be used to deliver cancer drugs to nearly any type of tumor